Placeholder

Letter from the Editor

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

SKU: 1685. Categories: , .

Product Description

There’s no doubt about it, times are tough. The headlines scream with news about “right sizing,” major layoffs due to the economy,  and major mergers and acquisitions that are creating redundancies across all functional areas. Even as this issue was going to press, it was reported that GlaxoSmithKline was in talks to acquire Stiefel Laboratories, a privately held manufacturer and marketer of skin-care pharmaceuticals. According to reports, the deal is valued at about $3 billion. If an agreement is reached, this would be the latest round of consolidation among drug companies, which are seeking to acquire pipelines and existing product lines in the face of generic pressure.
In light of these turbulent times, it’s more important than ever to make sure you are prepared. In this month’s forum, industry experts discuss various best practices to navigate a successful career path. It’s the exception rather than the rule these days for individuals to stay with one organization for their whole career. Therefore, overwhelmingly the No. 1 tip offered by our panel of thought leaders is to establish…

FEEDBACK